鉴定TLRs作为肺腺癌的潜在预后生物标志物

Junjie Ying1, Haihua Hong2, Chaoqun Yu3

  • 1Department of Thoracic Surgery, The People's Hospital of Beilun District, Ningbo, China.

Medicine
|September 25, 2023
PubMed
概括

收费类受体 (TLRs) 在肺腺癌 (LUAD) 中表达的变化. 特定的TLRs (TLR2/7/8) 可能作为有价值的预后生物标志物来改善LUAD患者的结果.